Cheryl K. Acton, a member of the Utah House of Representatives, shared a series of posts on December 10, 2025, addressing issues ranging from healthcare costs to drug policy and personal reflections.
In her first post at 08:02 UTC, Acton commented on the state of health insurance plans in the United States. She wrote, “Something’s gotta give! Families can’t pay outrageous premiums AND meet high deductibles. We used to call high deductible plans ‘catastrophic insurance,’ but now they’re commonplace. Many ppl who have ‘coverage’ can’t afford to use it because of the deductible threshold.” This statement reflects ongoing concerns about the affordability and accessibility of healthcare for American families.
Later that morning at 08:15 UTC, Acton addressed U.S. drug policy by stating, “We may call it the war on drugs, but we don’t recognize it as such. Maybe that’s because there are no front lines in this war and no territories to be won or lost. We can’t negotiate a treaty to end it. We must use every supply and demand tool avlb to eradicate this plague.”
In a separate post at 19:28 UTC, Acton shared two literary reflections: ‘”Your father is a mystery it takes your whole life to unravel.” “She had decided early on to live with the expectation of doom, an inspired tactic, because by expecting it, it never fully arrived.” 2/4’
High-deductible health plans have become increasingly common in recent years across the United States. While these plans were once considered primarily for catastrophic coverage—intended for rare but expensive medical events—they are now standard options for many Americans. As deductibles rise alongside premiums, some insured individuals find themselves unable to afford care despite having coverage.
The term “war on drugs” refers to government-led initiatives aimed at reducing illegal drug trade and use in the United States since the 1970s. Despite decades of enforcement efforts and public campaigns, challenges remain in both supply reduction and demand management strategies.
Acton’s remarks reflect ongoing debates over healthcare affordability and drug policy in both Utah and nationwide.
